TrialAlzheimer's research & therapy2017
A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.
Susanne Ostrowitzki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
284 papers cite itlatest 60 shown
this paperpooled ittrialcites it